SMAD2 and pulmonary arterial hypertension: Functional antagonism between SMAD1/5/8 and SMAD2/3 signaling pathways at multiple levels and under diverse pathologic conditions22,23 supports the hypothesis that imbalance between these two superfamily branches is central to PAH pathology15,16,24.